Minimally-Invasive Stenting Effectively Treats Painful Post-Thrombotic Syndrome
The 225-patient trial found better symptom relief and quality of life, but bleeding rose to 11% in the stent group, researchers reported.
5 Articles
5 Articles
Minimally-invasive stenting effectively treats painful post-thrombotic syndrome
A major multi-site clinical trial co-led by researchers at Washington University School of Medicine in St. Louis has shown that post-thrombotic syndrome - a common and often painful complication suffered by many people who have experienced blockages of major veins due to blood clots - can be effectively treated with a minimally invasive procedure.
Stenting Eases Hard-to-Treat Venous Disease After Deep Vein Thrombosis
(MedPage Today) -- Stenting and enhanced antithrombotic therapy together reduced the severity of post-thrombotic syndrome in the phase III C-TRACT trial -- albeit with patients left at higher bleeding risk. There was a significant improvement...
C-TRACT trial results hail "new era" for post-thrombotic syndrome following DVT
Suresh Vedantham presents the C-TRACT results at SIR 2026 “These patients have suffered in silence because few physicians are aware of this complication or know how to effectively treat it,” said Suresh Vedantham, an interventional radiology physician and professor of radiology at WashU Medicine Mallinckrodt Institute of Radiology in St Louis, USA, and principal investigator of the C-TRACT trial. The results of the National Institutes of Health …
C-TRACT Evaluates Endovascular Therapy to Treat Postthrombotic Syndrome After DVT
April 13, 2026—The Society of Interventional Radiology (SIR) announced results from the C-TRACT study, which is investigating the treatment of postthrombotic syndrome (PTS) after deep vein thrombosis (DVT). The study is sponsored by the National Institutes of Health with additional support from the SIR Foundation. It was co-led by Washington University School of Medicine in St. Louis, Missouri, and McMaster University in Hamilton, Canada. The st…
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium


